Shattuck Labs Inc — Cash Flow (NASDAQ:STTK) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Cash from operating activities 33.66 M57.12 M94.5 M81.23 M60.52 M 48.76 M Cash from investing activities 146.32 M10.44 M49.44 M110.86 M8.51 M -3.11 M Cash from financing activities 330.87 M1.93 M171 K48.62 M787 K 44.37 M Free cash flow 32.93 M49.19 M82.88 M80.82 M60.46 M 48.76 M

Notizie

Piper Sandler avvia copertura su Shattuck Labs con rating Overweight

Piper Sandler initiates Shattuck Labs stock with Overweight rating

Shattuck Labs: "Hold" On Oncology Exit And Competitive TL1A/DR3 Pathway Pivot (STTK)

Earnings season to kick off with

Shattuck's Bowel Disease Treatment Looks Promising: Analyst - Shattuck Labs (NASDAQ:STTK)

Shattuck Labs: rating del titolo migliorato a Buy da H.C. Wainwright

Shattuck Labs stock rating upgraded to Buy by H.C. Wainwright

Shattuck Labs, Inc. (STTK) Presents at The United European Gastroenterology (UEG) Congress UEG Week 2025 Transcript

Shattuck Labs al Congresso UEG: Nuove prospettive per il trattamento della IBD

Shattuck Labs at UEG Congress: Innovative IBD Treatment Insights

What Makes Shattuck Labs, Inc. (STTK) a Strong Momentum Stock: Buy Now?

Should You Buy Shattuck Labs, Inc. (STTK) After Golden Cross?